31 – 40 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281(
- Contribution to journal › Article
-
Mark
Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix
(
- Contribution to journal › Article
- 1998
-
Mark
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307(
- Contribution to journal › Article
-
Mark
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis
(
- Contribution to journal › Article
-
Mark
Nytt behandlingsprogram vid avancerad ovarialcancer. Tillfredsställande resultat med decentraliserad cytostatikaterapi
(
- Contribution to journal › Article
- 1997
-
Mark
Identification of TP53 gene mutations in uterine corpus cancer with short follow-up
(
- Contribution to journal › Article
-
Mark
Bättre prognos vid epitelial ovarialcancer
(
- Contribution to journal › Article
-
Mark
Malignant struma ovarii' with peritoneal dissemination
(
- Contribution to journal › Letter
-
Mark
Nytt, dyrare medel mot ovarialcancer. Ar det värt sitt pris?
(
- Contribution to journal › Article
- 1996
-
Mark
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility
(
- Contribution to journal › Article